Skanska to build AstraZeneca site

Neill Barston

18 February 2015

A computer generated image of the new AstraZeneca science facilities in Cambridge

A computer generated image of the new AstraZeneca science facilities in Cambridge

Skanska has gained an SEK3.7 billion (€388 million) construction contract for a research and development centre for the UK-based AstraZeneca science group.

Designed by Herzog & de Meuron, the new facility in Cambridge, which will also serve as corporate headquarters, will be built on the Cambridge Biomedical Campus.

The scheme will become the company’s largest centre for oncology research, offering facilities for 2,000 employees. Work has now started on the project, which is due to be completed in 2017.

Its development follows Skanska’s latest annual results, which showed year-on-year growth to SEK145.02 billion (€15.05 billion).

Construction
STAY CONNECTED



Receive the information you need when you need it through our world-leading magazines, newsletters and daily briefings.

Sign up

CONNECT WITH THE TEAM
Andy Brown Editor, Editorial, UK - Wadhurst Tel: +44 (0) 1892 786224 E-mail: [email protected]
Neil Gerrard Senior Editor, Editorial, UK - Wadhurst Tel: +44 (0) 7355 092 771 E-mail: [email protected]
Catrin Jones Deputy Editor, Editorial, UK – Wadhurst Tel: +44 (0) 791 2298 133 E-mail: [email protected]
Eleanor Shefford Brand Manager Tel: +44 (0) 1892 786 236 E-mail: [email protected]
CONNECT WITH SOCIAL MEDIA